AKT1 and colitis: In the present study, after SSP treatment of DSS-induced colitis for 7 days, PI3K and p-Akt proteins were inhibited and p-AMPKα was activated, which suggested that the therapeutic effect of SSP on experimental colitis was closely related to the PI3K/Akt signaling pathway.